Creative Biolabs is a global contract research organization founded by scientists with a strong commitment to advancing cancer research and therapeutic innovation. Over the years, the company has expanded its scientific expertise into a broad discovery infrastructure that supports pharmaceutical, biotechnology, and academic partners across multiple disease areas. Creative Biolabs provides customized, integrated solutions spanning antibody discovery and engineering, bispecific and single-domain antibody development, antibody-drug conjugates, phage display library systems, membrane protein discovery, gene therapy, cell therapy, mRNA research, and translational preclinical support. Its capabilities also include PK/PD and toxicity evaluation services, as well as specialized resources such as non-human primate biologicals to help researchers generate more translatable data for preclinical development. By combining proprietary technology platforms, multidisciplinary scientific teams, and a custom-service-centered model, Creative Biolabs helps clients bridge fundamental biology and clinical reality, accelerating the development of next-generation therapeutics and research tools worldwide.